Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Na Yin, Hui Yu, Xiaodi Zhang & Xiaodan Lv. (2020) Enhancement of Pancreatic Cancer Therapy Efficacy by Type-1 Matrix Metalloproteinase-Functionalized Nanoparticles for the Selective Delivery of Gemcitabine and Erlotinib. Drug Design, Development and Therapy 14, pages 4465-4475.
Read now
Read now
Jiamin Jin, Chunbo Teng & Tao Li. (2018) Combination therapy versus gemcitabine monotherapy in the treatment of elderly pancreatic cancer: a meta-analysis of randomized controlled trials. Drug Design, Development and Therapy 12, pages 475-480.
Read now
Read now
Articles from other publishers (32)
Daisy Evans, Nader Ghassemi, Shahab Hajibandeh, Shahin Hajibandeh, Saleh Romman, Richard W. Laing, Damien Durkin & Tejinderjit S. Athwal. (2023) Meta-analysis of adjuvant chemotherapy versus no adjuvant chemotherapy for resected stage I pancreatic cancer. Surgery.
Crossref
Crossref
Jia-Jun Zhong & Yan-Qing Ye. (2023) Construction and validation of a nomogram model for predicting early death in patients with metastatic pancreatic adenocarcinoma based on SEER database. World Chinese Journal of Digestology 31:14, pages 577-588.
Crossref
Crossref
Motahareh Mortazavi, Elaheh Raufi, Tahereh Damghani, Mehdi Khoshneviszadeh, Najmeh Edraki, Masoomeh Eskandari, Elisa Giovannetti, Godefridus J. Peters, Somayeh Pirhadi & Omidreza Firuzi. (2023) Discovery of anticancer agents with c-Met inhibitory potential by virtual and experimental screening of a chemical library. European Journal of Pharmacology 938, pages 175395.
Crossref
Crossref
Thomas Seufferlein, Julia Mayerle, Stefan Böck, Thomas Brunner, Thomas J. Ettrich, Lars Grenacher, Thomas Mathias Gress, Thilo Hackert, Volker Heinemann, Angelika Kestler, Marianne Sinn, Andrea Tannapfel, Ulrich Wedding & Waldemar Uhl. (2022) S3-Leitlinie zum exokrinen Pankreaskarzinom – Langversion 2.0 – Dezember 2021 – AWMF-Registernummer: 032/010OL. Zeitschrift für Gastroenterologie 60:11, pages e812-e909.
Crossref
Crossref
Chunhao Cao, Wenting Zhao, Xianglin Chen, Bin Shen, Teng Wang, Chaoxu Wu & Xiaofeng Rong. (2022) Deciphering the action mechanism of paeoniflorin in suppressing pancreatic cancer: A network pharmacology study and experimental validation. Frontiers in Pharmacology 13.
Crossref
Crossref
Hongjuan Yao, Wenping Song, Rui Cao, Cheng Ye, Li Zhang, Hebing Chen, Junting Wang, Yuchen Shi, Rui Li, Yi Li, Xiujun Liu, Xiaofei Zhou, Rongguang Shao & Liang Li. (2022) An EGFR/HER2-targeted conjugate sensitizes gemcitabine-sensitive and resistant pancreatic cancer through different SMAD4-mediated mechanisms. Nature Communications 13:1.
Crossref
Crossref
Christopher N Chin, Ty Subhawong, James Grosso, Jeremy R. Wortman, Lacey J. McIntosh, Ryan Tai, Marta Braschi-Amirfarzan, Patricia Castillo & Francesco Alessandrino. (2022) Teaching cancer imaging in the era of precision medicine: Looking at the big picture. European Journal of Radiology Open 9, pages 100414.
Crossref
Crossref
Ghmkin Hassan & Masaharu Seno. 2022. Cancer Stem Cell Markers and Related Network Pathways. Cancer Stem Cell Markers and Related Network Pathways
65
81
.
Joanne Lundy, Marion Harris, John Zalcberg, Allan Zimet, David Goldstein, Val Gebski, Adina Borsaru, Christopher Desmond, Michael Swan, Brendan J. Jenkins & Daniel Croagh. (2021) EUS-FNA Biopsies to Guide Precision Medicine in Pancreatic Cancer: Results of a Pilot Study to Identify KRAS Wild-Type Tumours for Targeted Therapy. Frontiers in Oncology 11.
Crossref
Crossref
Iris Bittmann. (2021) Medikamentös induzierte interstitielle LungenerkrankungenDrug-induced interstitial lung diseases. Wiener klinisches Magazin 24:5, pages 206-212.
Crossref
Crossref
Zhong Zhang, Juan Pu & Haijun Zhang. (2021) Development and Validation of a Simple-to-Use Nomogram to Predict Early Death in Metastatic Pancreatic Adenocarcinoma. Frontiers in Oncology 11.
Crossref
Crossref
O. D. Ostroumova, A. I. Listratov, A. I. Kochetkov & D. A. Sychev. (2021) Drugs associated with drug-induced interstitial lung diseases. Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice:2, pages 39-51.
Crossref
Crossref
Sara Cherri, Silvia Noventa & Alberto Zaniboni. (2021) Pancreatic adenocarcinoma: Beyond first line, where are we?. World Journal of Gastroenterology 27:17, pages 1847-1863.
Crossref
Crossref
Junxiong Wang, Shuo Yang, Li Min, Shengtao Zhu, Shuilong Guo & Shutian Zhang. (2021) ECT2 Increases the stability of EGFR and Tumorigenicity by Inhibiting Grb2 Ubiquitination in Pancreatic Cancer. Frontiers in Oncology 10.
Crossref
Crossref
Iris Bittmann. (2021) Medikamentös induzierte interstitielle LungenerkrankungenDrug-induced interstitial lung diseases. Der Pathologe 42:1, pages 11-16.
Crossref
Crossref
Marlene Mathuber, Hemma Schueffl, Orsolya Dömötör, Claudia Karnthaler, Éva A. Enyedy, Petra Heffeter, Bernhard K. Keppler & Christian R. Kowol. (2020) Improving the Stability of EGFR Inhibitor Cobalt(III) Prodrugs. Inorganic Chemistry 59:23, pages 17794-17810.
Crossref
Crossref
Jia-qiao Fan, Meng-Fei Wang, Hai-Long Chen, Dong Shang, Jugal K. Das & Jianxun Song. (2020) Current advances and outlooks in immunotherapy for pancreatic ductal adenocarcinoma. Molecular Cancer 19:1.
Crossref
Crossref
Deepanshi Dhar, Komal Raina, Dileep Kumar, Michael F. Wempe, Stacey M. Bagby, Todd M. Pitts, David J. Orlicky, Chapla Agarwal, Wells A. Messersmith & Rajesh Agarwal. (2020) Bitter melon juice intake with gemcitabine intervention circumvents resistance to gemcitabine in pancreatic patient‐derived xenograft tumors. Molecular Carcinogenesis 59:10, pages 1227-1240.
Crossref
Crossref
Yangyang Yue, Weikun Qian, Jie Li, Shiqi Wu, Mengzhao Zhang, Zheng Wu, Qingyong Ma & Zheng Wang. (2020) 2′-Hydroxyflavanone inhibits the progression of pancreatic cancer cells and sensitizes the chemosensitivity of EGFR inhibitors via repressing STAT3 signaling. Cancer Letters 471, pages 135-146.
Crossref
Crossref
Kim-Rouven Liedtke, Eric Freund, Maraike Hermes, Stefan Oswald, Claus-Dieter Heidecke, Lars-Ivo Partecke & Sander Bekeschus. (2020) Gas Plasma-Conditioned Ringer’s Lactate Enhances the Cytotoxic Activity of Cisplatin and Gemcitabine in Pancreatic Cancer In Vitro and In Ovo. Cancers 12:1, pages 123.
Crossref
Crossref
Yumi Harano, Akira Babazono, Takako Fujita & Peng Jiang. (2019) Efficacy of S-1 monotherapy for older patients with unresectable pancreatic cancer: A retrospective cohort study. Journal of Geriatric Oncology 10:3, pages 420-426.
Crossref
Crossref
Ruth Maron, Bilha Schechter, Nishanth Belugali Nataraj, Soma Ghosh, Donatella Romaniello, Ilaria Marrocco, Ashish Noronha, Silvia Carvalho, Yosef Yarden & Michael Sela. (2019) Inhibition of a pancreatic cancer model by cooperative pairs of clinically approved and experimental antibodies. Biochemical and Biophysical Research Communications 513:1, pages 219-225.
Crossref
Crossref
Qinlian Jiao, Lei Bi, Yidan Ren, Shuliang Song, Qin Wang & Yun-shan Wang. (2018) Advances in studies of tyrosine kinase inhibitors and their acquired resistance. Molecular Cancer 17:1.
Crossref
Crossref
Toshinori Ozaki, Meng Yu, Danjing Yin, Dan Sun, Yuyan Zhu, Youquan Bu & Meixiang Sang. (2018) Impact of RUNX2 on drug-resistant human pancreatic cancer cells with p53 mutations. BMC Cancer 18:1.
Crossref
Crossref
Sarah Skeoch, Nicholas Weatherley, Andrew Swift, Alexander Oldroyd, Christopher Johns, Conal Hayton, Alessandro Giollo, James Wild, John Waterton, Maya Buch, Kim Linton, Ian Bruce, Colm Leonard, Stephen Bianchi & Nazia Chaudhuri. (2018) Drug-Induced Interstitial Lung Disease: A Systematic Review. Journal of Clinical Medicine 7:10, pages 356.
Crossref
Crossref
Sandeep Kumar, Joseph R. Inigo, Rahul Kumar, Ajay K. Chaudhary, Jordan O'Malley, Srimmitha Balachandar, Jianmin Wang, Kristopher Attwood, Neelu Yadav, Steven Hochwald, Xinjiang Wang & Dhyan Chandra. (2018) Nimbolide reduces CD44 positive cell population and induces mitochondrial apoptosis in pancreatic cancer cells. Cancer Letters 413, pages 82-93.
Crossref
Crossref
Gui‐Feng Liu, Gui‐Jie Li & Hang Zhao. (2017) Efficacy and Toxicity of Different Chemotherapy Regimens in the Treatment of Advanced or Metastatic Pancreatic Cancer: A Network Meta‐Analysis. Journal of Cellular Biochemistry 119:1, pages 511-523.
Crossref
Crossref
Jin Jiang, Zuguo Yuan, Yiqing Sun, Yuan Bu, Wenfeng Li & Zhenghua Fei. (2017) Ginsenoside Rg3 enhances the anti-proliferative activity of erlotinib in pancreatic cancer cell lines by downregulation of EGFR/PI3K/Akt signaling pathway. Biomedicine & Pharmacotherapy 96, pages 619-625.
Crossref
Crossref
Kahina Hammam, Magali Saez-Ayala, Etienne Rebuffet, Laurent Gros, Sophie Lopez, Berengere Hajem, Martine Humbert, Emilie Baudelet, Stephane Audebert, Stephane Betzi, Adrien Lugari, Sebastien Combes, Sebastien Letard, Nathalie Casteran, Colin Mansfield, Alain Moussy, Paulo De Sepulveda, Xavier Morelli & Patrice Dubreuil. (2017) Dual protein kinase and nucleoside kinase modulators for rationally designed polypharmacology. Nature Communications 8:1.
Crossref
Crossref
Kim Rouven Liedtke, Sander Bekeschus, André Kaeding, Christine Hackbarth, Jens-Peter Kuehn, Claus-Dieter Heidecke, Wolfram von Bernstorff, Thomas von Woedtke & Lars Ivo Partecke. (2017) Non-thermal plasma-treated solution demonstrates antitumor activity against pancreatic cancer cells in vitro and in vivo. Scientific Reports 7:1.
Crossref
Crossref
Tulay Kus, Gokmen Aktas, Mehmet Emin Kalender, Alper Sevinc & Celaletdin Camci. (2016) Comparison of FOLFIRINOX Chemotherapy with Other Regimens in Patients with Biliary Tract Cancers: a Retrospective Study. Journal of Gastrointestinal Cancer 48:2, pages 170-175.
Crossref
Crossref
Jun XiaoHaibo Yu. (2017) Gemcitabine Conjugated Chitosan and Double Antibodies (Abc-GC-Gemcitabine Nanoparticles) Enhanced Cytoplasmic Uptake of Gemcitabine and Inhibit Proliferation and Metastasis In Human SW1990 Pancreatic Cancer Cells. Medical Science Monitor 23, pages 1613-1620.
Crossref
Crossref